EverQuote, Inc.
Business
EverQuote, Inc. operates an online marketplace that connects consumers seeking property and casualty insurance with insurance providers, including carriers and third-party agents. It offers consumer-facing insurance shopping experiences, lead generation and referral services, a web-based provider portal, campaign management tools, and call-center supported quote delivery. Key business components include its proprietary data and technology platform, provider engagement tools, consumer acquisition channels, and verified partner publisher network. The company primarily serves the U.S. P&C insurance market through owned websites, third-party publishers, call centers and direct integrations with carriers and agents.
Summary from filing dated 2025-02-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 693 | 500 | 288 | 404 | 419 | |
| Cost of revenue | 19 | 21 | 22 | 24 | 24 | |
| Sales and marketing | 541 | 388 | 240 | 349 | 355 | |
| Research and development | 32 | 30 | 28 | 32 | 36 | |
| General and administrative | 34 | 30 | 26 | 28 | 25 | |
| Legal settlement | 8 | — | — | — | — | |
| Restructuring and other charges | — | — | 24 | — | — | |
| Acquisition-related costs | — | — | −150,000 | −4 | 1 | |
| Total cost and operating expenses | 634 | 468 | 340 | 429 | 440 | |
| Income (loss) from operations | 58 | 32 | −52 | −25 | −22 | |
| Interest income | 4 | 2 | 1 | 349,000 | 37,000 | |
| Other income (expense), net | −87,000 | 178,000 | 14,000 | 23,000 | −57,000 | |
| Total other income, net | 3 | 2 | 1 | 372,000 | −20,000 | |
| Income (loss) before income taxes | 62 | 34 | −51 | −24 | −22 | |
| Income tax benefit (expense) | 37 | −2 | −577,000 | — | 3 | |
| Net income (loss) | 99 | 32 | −51 | −24 | −19 | |
| Basic (per share) | 2.75 | 0.92 | −1.54 | −0.77 | −0.67 | |
| Diluted (per share) | 2.63 | 0.88 | −1.54 | −0.77 | −0.67 | |
| Basic (shares) | 36 | 35 | 33 | 31,613 | 29,088 | |
| Diluted (shares) | 38 | 37 | 33 | 31,613 | 29,088 | |
| Foreign currency translation adjustment | 126,000 | −29,000 | 35,000 | −16,000 | 17,000 | |
| Comprehensive income (loss) | 99 | 32 | −51 | −24 | −19 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 171 | 102 | 38 | 31 | 35 | |
| Accounts receivable, net | 75 | 61 | 21 | 30 | 36 | |
| Commissions receivable, current portion | 0 | 3 | 4 | 14 | 9 | |
| Prepaid expenses and other current assets | 10 | 5 | 6 | 7 | 5 | |
| Total current assets | 256 | 172 | 69 | 81 | 85 | |
| Property and equipment, net | 8 | 6 | 6 | 6 | 6 | |
| Goodwill | 22 | 22 | 22 | 22 | 22 | |
| Acquired intangible assets, net | 0 | 3 | 5 | 8 | 10 | |
| Operating lease right-of-use assets | 2 | 3 | 2 | 6 | 7 | |
| Deferred tax assets | 39 | 0 | — | — | — | |
| Commissions receivable, non-current portion | 0 | 4 | 8 | 33 | 13 | |
| Other assets | 183,000 | 320,000 | 29,000 | 450,000 | 681,000 | |
| Total assets | 327 | 211 | 111 | 157 | 144 | |
| Accounts payable | 77 | 60 | 17 | 31 | 30 | |
| Accrued expenses and other current liabilities | 8 | 10 | 9 | 10 | 13 | |
| Deferred revenue | 2 | 2 | 2 | 2 | 2 | |
| Operating lease liabilities | 1 | 1 | 2 | 3 | 3 | |
| Total current liabilities | 87 | 73 | 30 | 45 | 47 | |
| Deferred tax liabilities | 281,000 | 0 | — | — | — | |
| Operating lease liabilities, net of current portion | 1 | 3 | 70,000 | 4 | 6 | |
| Total liabilities | 89 | 75 | 30 | 49 | 58 | |
| Commitments and contingencies (Note 11) | — | — | — | — | — | |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding | — | — | — | — | — | |
| Additional paid-in capital | 320 | 317 | 294 | 270 | 223 | |
| Accumulated other comprehensive income | 126,000 | 0 | 29,000 | −6,000 | 10,000 | |
| Accumulated deficit | −82 | −181 | −213 | −162 | −138 | |
| Total stockholders' equity | 238 | 135 | 81 | 107 | 85 | |
| Total liabilities and stockholders' equity | 327 | 211 | 111 | 157 | 144 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | 99 | 32 | −51 | −24 | −19 | |
| Depreciation and amortization expense | 4 | 6 | 6 | 6 | 5 | |
| Stock-based compensation expense | 24 | 21 | 24 | 29 | 30 | |
| Deferred taxes | −38 | — | — | — | −3 | |
| Loss on sale of health assets | — | — | 19 | — | — | |
| Impairment of right-of-use asset | — | — | 384,000 | — | — | |
| Change in fair value of contingent consideration liabilities | — | — | −150,000 | −4 | 196,000 | |
| Provision for bad debt | 10,000 | 13,000 | 204,000 | 693,000 | −41,000 | |
| Unrealized foreign currency transaction (gains) losses | 110,000 | −26,000 | 21,000 | −9,000 | 24,000 | |
| Litigation accrual settled with sale of assets | 8 | — | — | — | — | |
| Accounts receivable | −14 | −40 | 8 | 5 | 11 | |
| Prepaid expenses and other current assets | −4 | 440,000 | 962,000 | −2 | 2 | |
| Commissions receivable, current and non-current | 2 | 5 | 4 | −24 | −17 | |
| Operating lease right-of-use assets | 1 | 2 | 2 | 3 | 3 | |
| Other assets | 137,000 | −291,000 | 421,000 | −19,000 | 534,000 | |
| Accounts payable | 17 | 43 | −13 | 1 | −4 | |
| Accrued expenses and other current liabilities | −2 | 1 | −2 | −2 | 3 | |
| Deferred revenue | −103,000 | −107,000 | 5,000 | −229,000 | 227,000 | |
| Operating lease liabilities | −1 | −3 | −3 | −3 | −3 | |
| Net cash provided by (used in) operating activities | 95 | 67 | −3 | −16 | 7 | |
| Acquisition of property and equipment, including costs capitalized for development of internal-use software | −5 | −4 | −4 | −4 | −3 | |
| Proceeds from sale of health assets | — | — | 13 | — | — | |
| Net cash provided by (used in) investing activities | −5 | −4 | 9 | −4 | −19 | |
| Proceeds from exercise of stock options | 4 | 4 | 979,000 | 942,000 | 4 | |
| Repurchase of common stock | −21 | — | — | — | — | |
| Tax withholding payments related to net share settlement | −4 | −2 | −402,000 | −100,000 | — | |
| Net cash provided by (used in) financing activities | −21 | 2 | 577,000 | 16 | 4 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 3,000 | 1,000 | 18,000 | −27,000 | −6,000 | |
| Net increase in cash, cash equivalents and restricted cash | 69 | 64 | 7 | −4 | −8 | |
| Acquisition of property and equipment included in accounts payable | 125,000 | 135,000 | 25,000 | 60,000 | 100,000 | |
| Assets sold in settlement of litigation accrual | 8 | — | — | — | — | |
| Operating lease liabilities arising from obtaining right-of-use assets | 0 | 4 | 0 | 1 | 383,000 |